Displaying 25 - 33 of 33
Metabolism, Alcohol & Toxicity

MAFLD – the importance of early identification and interventio

Webcasts
View
Metabolism, Alcohol & Toxicity

MAFLD-associated metabolic risks in obesity and diabetes – insights from clinical practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Sanofi: "Global Liver Health Forum 2023 – Expert's exchange" (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A and panel discussion

Webcasts
View
Metabolism, Alcohol & Toxicity

Summary and closing remarks

Webcasts
View
Metabolism, Alcohol & Toxicity

The NASH care pathway: Drivers and emerging trends

Webcasts
View
Metabolism, Alcohol & Toxicity

How to optimise NASH patient care? – Collaboration with different specialities

Webcasts
View
Metabolism, Alcohol & Toxicity

How do non-invasive techniques improve patient identification and risk stratification?

Webcasts
View
Metabolism, Alcohol & Toxicity

Future improvements needed for care pathways for patients with NASH – Q&A

Webcasts
View
Displaying 25 - 33 of 33